At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
HRMY Harmony Biosciences Holdings, Inc.
Pre-Market Trading 07-01 06:28:03 EDT
30.17
-1.31
-4.16%
High31.89
Low30.13
Vol802.79K
Open31.60
D1 Closing31.48
Amplitude5.61%
Mkt Cap1.71B
Tradable Cap1.05B
Total Shares56.79M
T/O24.41M
T/O Rate2.32%
Tradable Shares34.64M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Harmony Biosciences Says FDA Denies Short Seller Claims Over Narcolepsy Drug Safety
BRIEF-Harmony Biosciences Presents Positive Data For Pitolisant In The Treatment Of Excessive Daytime Sleepiness And Fatigue In Myotonic Dystrophy Type 1
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. It offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.